1274 related articles for article (PubMed ID: 18492606)
41. [Mechanisms of action of transportation of liposomes and chitosan-coated liposomes containing leuprolide across intestine and Caco-2 cell].
Guo JX; Ping QN; Dong J; Li ZR; Li CJ
Yao Xue Xue Bao; 2005 Jan; 40(1):65-70. PubMed ID: 15881330
[TBL] [Abstract][Full Text] [Related]
42. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
[TBL] [Abstract][Full Text] [Related]
43. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luessen HL; de Boer BG; Verhoef JC; Junginger HE
Eur J Pharm Biopharm; 1999 May; 47(3):269-74. PubMed ID: 10382111
[TBL] [Abstract][Full Text] [Related]
44. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
45. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs.
Duhem N; Rolland J; Riva R; Guillet P; Schumers JM; Jérome C; Gohy JF; Préat V
Int J Pharm; 2012 Feb; 423(2):452-60. PubMed ID: 22212463
[TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
Chen F; Zhang ZR; Yuan F; Qin X; Wang M; Huang Y
Int J Pharm; 2008 Feb; 349(1-2):226-33. PubMed ID: 17825506
[TBL] [Abstract][Full Text] [Related]
47. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
48. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
[TBL] [Abstract][Full Text] [Related]
49. Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells.
Duizer E; van der Wulp C; Versantvoort CH; Groten JP
J Pharmacol Exp Ther; 1998 Oct; 287(1):395-402. PubMed ID: 9765361
[TBL] [Abstract][Full Text] [Related]
50. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
51. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability.
Zerrouk N; Corti G; Ancillotti S; Maestrelli F; Cirri M; Mura P
Eur J Pharm Biopharm; 2006 Apr; 62(3):241-6. PubMed ID: 16226882
[TBL] [Abstract][Full Text] [Related]
52. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
53. Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing.
Muendoerfer M; Schaefer UF; Koenig P; Walk JS; Loos P; Balbach S; Eichinger T; Lehr CM
Int J Pharm; 2010 Jun; 392(1-2):134-40. PubMed ID: 20347022
[TBL] [Abstract][Full Text] [Related]
54. The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like Caco-2 cells.
Jewell C; Cusack S; Cashman KD
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):163-71. PubMed ID: 15664300
[TBL] [Abstract][Full Text] [Related]
55. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Thanou M; Verhoef JC; Marbach P; Junginger HE
J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
[TBL] [Abstract][Full Text] [Related]
56. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis.
De Walle JV; Sergent T; Piront N; Toussaint O; Schneider YJ; Larondelle Y
Toxicol Appl Pharmacol; 2010 Jun; 245(3):291-8. PubMed ID: 20362602
[TBL] [Abstract][Full Text] [Related]
57. Transport of leuprolide across rat intestine, rabbit intestine and Caco-2 cell monolayer.
Guo J; Ping Q; Jiang G; Dong J; Qi S; Feng L; Li Z; Li C
Int J Pharm; 2004 Jul; 278(2):415-22. PubMed ID: 15196645
[TBL] [Abstract][Full Text] [Related]
58. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
[TBL] [Abstract][Full Text] [Related]
59. The effect of nicotine in vitro on the integrity of tight junctions in Caco-2 cell monolayers.
McGilligan VE; Wallace JM; Heavey PM; Ridley DL; Rowland IR
Food Chem Toxicol; 2007 Sep; 45(9):1593-8. PubMed ID: 17399881
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation.
Zambito Y; Fogli S; Zaino C; Stefanelli F; Breschi MC; Di Colo G
Eur J Pharm Sci; 2009 Sep; 38(2):112-20. PubMed ID: 19576984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
